0      0


LV08 - New Drug Updates: Solid Tumors


‐ Nov 11, 2023 10:15am

Disclosures:

Lisa Holle has no relevant financial relationships to disclose.


Learning Objectives:

  • Review the approved label indications of new drugs and biologics in hematology/oncology.
  • Describe the mechanisms of action for recently approved drugs and biologics in hematology/oncology.
  • Develop plans to monitor and manage side effects associated with administration of newly approved drugs and biologics in hematology/oncology.

Speaker(s):

You must be logged in and own this session in order to post comments.